Home / News Article

Prosidio Appoints Former ENT&A CEO Robert Glazer as Strategic Advisor to Enhance Surgical Visualization Accessibility

Reportable - Pharma and Biotech News August 2, 2025
By Reportable Staff
Read Original Article →
Prosidio Appoints Former ENT&A CEO Robert Glazer as Strategic Advisor to Enhance Surgical Visualization Accessibility

Summary

Prosidio's appointment of Robert Glazer as a strategic advisor marks a significant step towards making advanced endoscopy technology accessible to outpatient practices, leveraging his expertise to bridge the gap between high-tech solutions and private practice needs.

Full Article

Prosidio, a leader in surgical-visualization technology, has announced the appointment of Robert (Bob) Glazer, the former Chief Executive Officer of ENT and Allergy Associates (ENT&A), as a strategic advisor. This move is poised to significantly impact the accessibility of premium endoscopy technology for outpatient practices. Glazer's vast experience in expanding physician practices, notably growing ENT&A from 40 to over 300 physicians across 60 locations, positions him as a key figure in guiding Prosidio's commercial strategy and distribution partnerships.

The significance of Glazer's appointment lies in his deep understanding of the challenges faced by private practices, particularly in balancing clinical excellence with financial constraints. Prosidio's innovative technology, which condenses an entire endoscopy tower into a compact, suitcase-sized 4K platform, is a breakthrough in making hospital-grade visualization affordable for smaller practices. Glazer's role will be instrumental in accelerating the adoption of this technology, ensuring that advanced medical tools are not just reserved for large hospitals but are accessible to all.

Jonathan Simmonds, MD, co-founder and CEO of Prosidio, emphasized the alignment between Glazer's vision for transforming outpatient care and Prosidio's mission. The company's commitment to providing cutting-edge, affordable, and effective tools resonates with Glazer's proven track record of driving growth and adoption in the medical field. This collaboration is a testament to Prosidio's dedication to empowering surgeons with world-class visualization tools, irrespective of their practice size or location.

Glazer expressed his enthusiasm for the opportunity to work with Prosidio, highlighting the company's innovative approach to endoscopy as a potential game-changer for private practices. By leveraging Prosidio's technology and Glazer's expertise, the partnership aims to revolutionize the accessibility of surgical visualization. This initiative not only promises to enhance the quality of care provided by outpatient practices but also ensures that high-quality surgical visualization is within reach for patients everywhere, marking a significant step forward in the democratization of medical technology.

QR Code for Content Provenance

This story is based on an article that was registered on the blockchain. The original source content used for this article is located at 24-7 Press Release